Hung Kuo-Sheng, Howng Shen-Long
Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
J Neurosurg. 2003 Nov;99(5):886-92. doi: 10.3171/jns.2003.99.5.0886.
Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. It is nearly uniformly fatal, with a median survival time of approximately 1 year, despite modem treatment modalities. Nevertheless, a range of survival times exists around this median. Efforts to understand why some patients live longer or shorter than the average may provide insight into the biology of these neoplasms. The annexin VII (ANX7) gene is located on the human chromosome 10q21, a site long hypothesized to harbor tumor suppressor genes associated with prostate and other cancers. To test whether ANX7 expression might be a predictor for GBMs, we examined ANX7 expression, p53 accumulation, and the MIB-1 labeling index in a retrospective series of 99 GBMs.
In all 99 cases, the patient's age, Karnofsky Performance Scale (KPS) score before surgery, extent of surgery, tumor location, and immunohistochemical features were analyzed using univariate and multivariate analyses to identify whether any significance exists among ANX7 expression, p53 accumulation, the MIB-1 labeling index, and survival time. Kaplan-Meier analyses demonstrated that a higher KPS score before surgery (< 0.0001), total tumor excision (p = 0.0072), young patient age (p = 0.03), and ANX7 expression (p = 0.0006) correlated with longer survival. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p < 0.0001), independent of all other variables. In addition, ANX7 expression correlated with higher MIB-1 immunostaining, but did not correlate with p53 accumulation. Moreover, a significant positive correlation was observed between p53 and MIB-1 staining.
These findings indicate that a higher KPS score before surgery, total tumor excision, young patient age, and ANX7 expression correlate with longer survival in patients with GBMs. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p < 0.0001) and was independent of all other variables.
多形性胶质母细胞瘤(GBM)是成人中最常见且致命的原发性脑肿瘤。尽管有现代治疗方式,但它几乎无一例外是致命的,中位生存时间约为1年。然而,在这个中位生存时间周围存在一系列不同的生存时间。努力去理解为什么有些患者生存时间比平均水平长或短,可能会为这些肿瘤的生物学特性提供见解。膜联蛋白VII(ANX7)基因位于人类染色体10q21,长期以来人们一直假设该位点存在与前列腺癌和其他癌症相关的肿瘤抑制基因。为了测试ANX7表达是否可能是GBM的一个预测指标,我们在一个回顾性系列研究中检测了99例GBM中的ANX7表达、p53蓄积和MIB - 1标记指数。
在所有99例病例中,使用单因素和多因素分析来分析患者的年龄、术前卡氏功能状态评分(KPS)、手术范围、肿瘤位置和免疫组化特征,以确定ANX7表达、p53蓄积、MIB - 1标记指数和生存时间之间是否存在任何显著相关性。Kaplan - Meier分析表明,术前较高的KPS评分(<0.0001)、肿瘤全切(p = 0.0072)、患者年龄较轻(p = 0.03)和ANX7表达(p = 0.0006)与较长的生存期相关。多因素Cox回归分析表明,ANX7表达是预后的最强预测指标(p < 0.0001),独立于所有其他变量。此外,ANX7表达与较高的MIB - 1免疫染色相关,但与p53蓄积无关。而且,在p53和MIB - 1染色之间观察到显著的正相关。
这些发现表明,术前较高的KPS评分、肿瘤全切、患者年龄较轻和ANX7表达与GBM患者较长的生存期相关。多因素Cox回归分析表明,ANX7表达是预后的最强预测指标(p < 0.0001),且独立于所有其他变量。